Profile for Vertex Pharmaceuticals Incorporated (VRTX)

$ 234.61   0.62 (+0.26%) Volume: 1.13m 4:00 PM EST Jan 22, 2020
After Hours:  $ 236.00   1.39 (+0.59%) Volume: 30.85k 6:39 PM EST Jan 22, 2020
Business Description:
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.
Address: 50 Northern Avenue, Boston, MA, USA, 02210
Telephone: +1 617 341-6100 Website: http://www.vrtx.com
Facsimile: N/A Email: [email protected]
Details
CEO: Jeffrey M Leiden
Employees: 2,500 Market Cap: 60.33b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology, DJ US Biotechnology, Morningstar Developed Markets Americas PR USD, Morningstar Developed Markets PR USD, Morningstar Exponential Technologies PR USD, Morningstar Global Markets PR USD, Morningstar Narrow Moat PR USD, Morningstar US Defensive Super Sector PR USD, Morningstar US Growth PR USD, Morningstar US Healthcare Sector PR USD, Morningstar US Large Cap PR USD, Morningstar US Large Growth PR USD, Morningstar US Large-Mid Cap PR USD, Morningstar US Large-Mid Growth PR USD, Morningstar US Market Factor Tilt PR USD, Morningstar US Market PR USD, Morningstar US Target Market Exposure PR USD, S&P 400 - Biotechnology (Sub Ind), S&P 500
Industry Classifications
Sector: Healthcare CIK: 875320
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)